user avatar
IdoAmitLab
@IdoAmitLab
Single Cell Gescheft @WeizmannScience
ישראל
weizmann.ac.il/immunology/Ami…
Joined November 2017
490
Following
17.3K
Followers
Posts
  • Pinned
    user avatar
    IdoAmitLab
    @IdoAmitLab
    Jan 22
    What if we could turn the tumor’s deadliest tricks against it? New @Cancer_Cell: Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells. Led by @GalYagel, @D_Rimini & @MVLocquenghien (1/15) cell.com/cancer-cell/ab…
    13K
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Dec 21, 2023
    We are very excited to present the development of Zman-seq (“Zman”, Hebrew for “time”), the 1st technology that measures single-cell transcriptomes and physical time in vivo, led by @D_Birschenkaum, @CuriousKX, @FlorianIngelfi1, @AssafWeiner sciencedirect.com/science/articl…. (1/19)
    203K
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Aug 11, 2020
    We are very excited to present INs-seq, a new technology for massively parallel single-cell RNA-sequencing (scRNA-seq) integrated with recording of intracellular protein activities. Developed by @YonatanKatza @FadiSheban @AdamYalin and @AssafWeiner cell.com/cell/fulltext/… (1/14)
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Jun 16, 2025
    Thank you everyone for the amazing support, we will definitely need your help down the road. We will rebuild everything that is broken - because we are not done.
    57K
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Apr 27, 2023
    We're thrilled to share our recent @NatureMedicine study, cracking the decades-old mystery surrounding the identity of cells responsible for producing erythropoietin (Epo) - the key regulator of erythropoiesis and oxygen homeostasis in our bodies. nature.com/articles/s4159… (1/16)
    224K
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Mar 9, 2020
    We are excited to present PIC-seq, a novel single cell technology for investigating cell-cell interactions, developed by @AmirGiladi and @meravcohen8, in collaboration with Amos Tanay. (1/11) nature.com/articles/s4158…
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Jul 11, 2019
    when you had a looong day in the lab but it was worth it (and you have fun people around) #peopleofIdoAmitLab #BottleCapChallege #bottletopchallenge @FadiSheban @YonatanKatza
    00:00
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Mar 3, 2022
    We are excited to share our @NatureCancer paper showing how interactions between subtypes of T and dendritic cells shape the tumor microenvironment in patients with different types of cancers and can enhance the response to checkpoint blockade therapy
    Content cover image
    The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and...
    From nature.com
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Dec 12, 2019
    Super excited to share our work on microglia diversity across evolution by @microgliaandme Eyal David @HadasKerenShaul @AssafWeiner and co. Now in @CellCellPress ! cell.com/cell/fulltext/…
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Sep 12, 2023
    Proud to share our collaboration in the latest @CellCellPress paper led by @li_hanjie. The study presents an immune cell atlas & the dynamics of human macrophage specification in prenatal development. doi.org/10.1016/j.cell… (1/11)
    82K
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Nov 18, 2021
    Who said libraries have to be quiet? 😉
    00:00
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    May 8, 2020
    We are excited to share ‘Host-viral infection maps reveal signatures of severe COVID-19 patients’ cell.com/cell/fulltext/… led by @bost_pierre and @AmirGiladi. Collab with the Zheng Lab from the Shenzhen Third People’s Hospital and Benno Schwikowski from @institutpasteur 1/13
    Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients
    From cell.com
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Apr 26, 2022
    Excited and honored to have been awarded @ERC_Research Advanced Grant for our project „TROJEN-Cell“. A new program for synthetic immunology aiming to revolutionize the landscape of immunotherapy. Synthetic, systems immunology and cell therapy enthusiasts are welcome to apply!
  • user avatar
    IdoAmitLab
    @IdoAmitLab
    Apr 21, 2022
    We are excited to share our @NatureBiotech paper introducing DestVI for identifying continuous cellular states in spatial transcriptomics (ST) data nature.com/articles/s4158…